Long Term Study With B2036-PEG
Long Term Study With B2036-PEG
Primary objective: To investigate the efficacy and safety of Pegvisomant in Japanese patients
 with acromegaly.
Inclusion Criteria:

 -  Patients with acromegaly who have received at least one dose of B2036-PEG in the
 preceding study (A6291009).

 Exclusion Criteria:

 -  Switching to other therapeutic methods for acromegaly